197 related articles for article (PubMed ID: 34078930)
1. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.
AlSawaftah NM; Awad NS; Paul V; Kawak PS; Al-Sayah MH; Husseini GA
Sci Rep; 2021 Jun; 11(1):11589. PubMed ID: 34078930
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system.
AlSawaftah NM; Paul V; Kosaji D; Khabbaz L; Awad NS; Husseini GA
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):111-120. PubMed ID: 35543613
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.
Awad NS; Paul V; Mahmoud MS; Al Sawaftah NM; Kawak PS; Al Sayah MH; Husseini GA
ACS Biomater Sci Eng; 2020 Jan; 6(1):48-57. PubMed ID: 33463192
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
5. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Hong M; Zhu S; Jiang Y; Tang G; Pei Y
J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867
[TBL] [Abstract][Full Text] [Related]
7. Transferrin Modified Dioscin Loaded PEGylated Liposomes: Characterization and
Wang Y; Yang Y; Yu Y; Li J; Pan W; Yang X; Zhang Z; Jiang S; Yang X; Wang X
J Nanosci Nanotechnol; 2020 Mar; 20(3):1321-1331. PubMed ID: 31492291
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid.
Sriraman SK; Salzano G; Sarisozen C; Torchilin V
Eur J Pharm Biopharm; 2016 Aug; 105():40-9. PubMed ID: 27264717
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
Awad NS; Paul V; Al-Sayah MH; Husseini GA
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):705-714. PubMed ID: 30873869
[TBL] [Abstract][Full Text] [Related]
10. Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound.
Ben Daya SM; Paul V; Awad NS; Al Sawaftah NM; Al Sayah MH; Husseini GA
J Biomed Nanotechnol; 2021 Jan; 17(1):90-99. PubMed ID: 33653499
[TBL] [Abstract][Full Text] [Related]
11. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
12. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
13. Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition.
Chen J; Yao J; Ma Z; Peng P; Lu S; Hu Y; Xu F; Yang Y; Yang X
J Liposome Res; 2017 Mar; 27(1):21-31. PubMed ID: 26911560
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
15. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
16. Liposomes Incorporating Transferrin and Stearic Acid-modified Octa-arginine for siRNA Delivery.
Yang D; Yang X; Lee RJ; Liu S; Xie J
Anticancer Res; 2017 Apr; 37(4):1759-1764. PubMed ID: 28373438
[TBL] [Abstract][Full Text] [Related]
17. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-triggered herceptin liposomes for breast cancer therapy.
Elamir A; Ajith S; Sawaftah NA; Abuwatfa W; Mukhopadhyay D; Paul V; Al-Sayah MH; Awad N; Husseini GA
Sci Rep; 2021 Apr; 11(1):7545. PubMed ID: 33824356
[TBL] [Abstract][Full Text] [Related]
19. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes.
Gijsens A; Derycke A; Missiaen L; De Vos D; Huwyler J; Eberle A; de Witte P
Int J Cancer; 2002 Sep; 101(1):78-85. PubMed ID: 12209592
[TBL] [Abstract][Full Text] [Related]
20. Formulation development and in vitro evaluation of transferrin-conjugated liposomes as a carrier of ganciclovir targeting the retina.
Asasutjarit R; Managit C; Phanaksri T; Treesuppharat W; Fuongfuchat A
Int J Pharm; 2020 Mar; 577():119084. PubMed ID: 31988033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
